Search research articles
Contact Us
Filters
Showing results (191-200 of 259) with videos related to
Page
of 26
Sort By:
The Oncologist
|
April 14, 2018
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
Kelly J Norsworthy, Chia-Wen Ko, Jee Eun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2019
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome
Yvette L Kasamon, Haiyan Chen, R Angelo de Claro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2017
FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Nicole J Gormley, Chia-Wen Ko, Albert Deisseroth, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
February 27, 2020
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease
Bellinda L King-Kallimanis, Tanya Wroblewski, Virginia Kwitkowski, et al.
The Oncologist
|
April 7, 2018
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q Le, Liang Li, Weishi Yuan, et al.
Cytometry. Part B, Clinical Cytometry
|
June 26, 2015
Regulatory perspective on minimal residual disease flow cytometry testing in multiple myeloma
Nicole J Gormley, Danielle M Turley, Jennifer S Dickey, et al.
Irish Medical Journal
|
April 27, 2026
Significant Laryngeal Trauma following Dog Bite
A McHugh, R Alshamassi, P Rohan, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
August 26, 2010
The University of North Carolina at Chapel Hill School of Medicine
W P Newton, K Stone, G A Dent, et al.
The Oncologist
|
March 28, 2019
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma
Nicholas C Richardson, Yvette L Kasamon, Haiyan Chen, et al.
Food and Nutrition
|
January 1, 1978
Functional classification of undernourished populations in the Republic of El Salvador. Methodological development
V Valverde, F Trowbridge, I Beghin, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 259) with videos related to
Sort By:
Page
of 26
The Oncologist
|
April 14, 2018
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
Kelly J Norsworthy, Chia-Wen Ko, Jee Eun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2019
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome
Yvette L Kasamon, Haiyan Chen, R Angelo de Claro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2017
FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Nicole J Gormley, Chia-Wen Ko, Albert Deisseroth, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
February 27, 2020
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease
Bellinda L King-Kallimanis, Tanya Wroblewski, Virginia Kwitkowski, et al.
The Oncologist
|
April 7, 2018
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q Le, Liang Li, Weishi Yuan, et al.
Cytometry. Part B, Clinical Cytometry
|
June 26, 2015
Regulatory perspective on minimal residual disease flow cytometry testing in multiple myeloma
Nicole J Gormley, Danielle M Turley, Jennifer S Dickey, et al.
Irish Medical Journal
|
April 27, 2026
Significant Laryngeal Trauma following Dog Bite
A McHugh, R Alshamassi, P Rohan, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
August 26, 2010
The University of North Carolina at Chapel Hill School of Medicine
W P Newton, K Stone, G A Dent, et al.
The Oncologist
|
March 28, 2019
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma
Nicholas C Richardson, Yvette L Kasamon, Haiyan Chen, et al.
Food and Nutrition
|
January 1, 1978
Functional classification of undernourished populations in the Republic of El Salvador. Methodological development
V Valverde, F Trowbridge, I Beghin, et al.
Page
of 26